Skip to content

Author

A. D. Sidorova

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Modern glucose-lowering drugs SGLT2 inhibitors and GLP-1 agonists in the prevention of cardiovascular disease and dementia in patients with diabetes and metabolic disorders

Cardiovascular diseases (CVD) and dementia are two leading causes of mortality and disability in the aging population, and their shared metabolic foundation (insulin resistance, chronic inflammation, and vascular dysfunction) opens new opportunities for pharmacological prevention. Modern glucose-lowering drugs, i.e. so...

E. N. Saykina, A. O. Kenkishvili, M. Maksimov et al. · 0 citations
Review Sep 2026

Prevention and treatment strategy for onychomycosis: a guide for physicians and pharmacists

This article reviews current strategies for the treatment and prevention of onychomycosis, a chronic fungal nail infection, the global prevalence of which reaches 20% or higher in high-risk groups (the elderly, patients with diabetes mellitus, and the immunocompromised). The authors examine the etiological profile (dom...

Yu. A. Akulinina, M. Maksimov, A. Danilov et al. · 0 citations
Review Sep 2026

Topical and systemic therapy for onychomycosis: modern approaches and drug selection

This article presents a clinical-pharmacological overview of current approaches to treating onychomycosis, the most common fungal nail infection, with a global prevalence of approximately 4–5.5%. It examines the epidemiology, etiological profile (characterized by the predominance of Trichophyton rubrum and an increasin...

M. Maksimov, Yu. A. Akulinina, A. D. Sidorova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.